AAV vectors containing the astrocyte-specific Gfa2 promoter to target hippocampal astrocytes and interfere with the biochemical cascades leading to astrocyte activation in APP/PS1 mice confirmed a deleterious role for activated astrocytes in AD. This evidence concerns the gene PSEN1 and Alzheimer disease.